FDA delay for ph 3 trial approval, page-51

And there in lies one of the main problems Avizia.
You say you have attended a company presentation.
PAR management spearheaded by Paul Rennie,
has proven to be totally untrustworthy over a long
period of time. Any claims/ forecasts/projections
by Rennie are treated with a great deal of cynicism
by many shareholders on these threads. We are
hoping fervently that despite managements
continual incompetence, iPPS will finally gain
regulatory approval.

That said, as the share price has continued to
fall over the last 18 months, I have added to our
small holding in small increments. My wife says
I like living on the edge. She is probably right.
At my age, I should have more sense.